Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on the tablet surface due to microbial contamination. The observance of black spots was reported in a product quality complaint
Similar Posts
Pharmaceutical Quality Resources
FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.Kabana Skin Care LLC – 710232 – 07/18/2025
CGMP/Finished Pharmaceuticals/AdulteratedTofersen approved by the MHRA to treat rare inherited form of motor neurone disease
New genetic therapy approved for SOD1-ALS brings targeted treatment option to patients in the UK
Professor James Levine: When policy becomes medicine
How regulation can spark life-saving innovation.
Hunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA 483 Issued 3/11/2015
Hunter Holmes McGuire Veterans Admin Medical Center, Richmond, VA 483 Issued 3/11/2015Supplying authorised medicines to Northern Ireland
What you need to do to supply authorised medicines from Great Britain to Northern Ireland.
